Once more JULABO concluded a successful exhibition at this year's Analytica in Munich. A new booth concept, innovative products and a large number of interested visitors contributed to an auspicious appearance by JULABO.
Bibby Scientific’s new web-based platform brings together special offers on products from all four of the company’s internationally recognised brands: Stuart, Jenway, Techne and Electrothermal
A new 3D printing process developed at the University of Glasgow could revolutionise the way scientists, doctors and even the general public create chemical products.
The new SM5 Mini Stirrer from Stuart packs the power to stir volumes up to 1 litre and even offers a choice of three stylish fascia designs. This versatile and economical magnetic stirrer is very simple to operate, providing stirring speeds of 350 to 2,000 rpm.
Roche has announced that the SUMMACTA study met its primary endpoint, showing comparable efficacy of the subcutaneous (SC) formulation of RoACTEMRA (tocilizumab, known as ACTEMRA outside Europe) 162mg weekly compared to 8 mg/kg RoACTEMRA intravenous (IV) formulation every 4 weeks.
Sartorius Stedim Biotech (SSB), a leading international pharma and biotech supplier, has substantially extended its supply chain security practices.
Roche has announced the launch and immediate availability of the GS GType TET2/CBL/KRAS and the GS GType RUNX1 Primer Sets for comprehensive genetic variation detection in four key human genes using the company’s 454 GS Junior and GS FLX Systems
Type 1 diabetes is the most prevalent metabolic disorder among young people. The origins of the disease remain unknown, but an effective therapy with permanent results and without side effects may be found in the near future.
The one year results from a study into whether two drug treatments (Lucentis and Avastin), are equally effective in treating neovascular or wet age-related macular degeneration (wet AMD), have been reported at an international research meeting in Fort Lauderdale, Florida.
A key protein, which may be activated to protect nerve cells from damage during heart failure or epileptic seizure, has been found to regulate the transfer of information between nerve cells in the brain. The discovery, made by neuroscientists at the University of Bristol and published in Nature Neuroscience and PNAS, could lead to novel new therapies for stroke and epilepsy.
Chemists and biologists from the University of Bristol have finally cracked one of the longest standing chemical mysteries. In a paper published today in PNAS, the team demonstrate exactly how an unusual class of compounds known as tropolones are synthesised in fungi.
An international team of researchers has made a major discovery that could lead to more effective treatment of severe pain using morphine.
View digital magazine
